Page last updated: 2024-09-04

dx 8951 and capecitabine

dx 8951 has been researched along with capecitabine in 1 studies

Compound Research Comparison

Studies (dx 8951)	Trials (dx 8951)	Recent Studies (post-2010) (dx 8951)	Studies (capecitabine)	Trials (capecitabine)	Recent Studies (post-2010) (capecitabine)
73	18	15	5,318	1,719	3,282

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chua, YJ; Cunningham, D	1

Reviews

1 review(s) available for dx 8951 and capecitabine

Article	Year
Chemotherapy for advanced pancreatic cancer. Best practice & research. Clinical gastroenterology, 2006, Volume: 20, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Fluorouracil; Gemcitabine; Glutamates; Guanine; Humans; Irinotecan; Organoplatinum Compounds; Palliative Care; Pancreatic Neoplasms; Pemetrexed; Taxoids; Topoisomerase I Inhibitors	2006

Article

Year

Chemotherapy for advanced pancreatic cancer.

Best practice & research. Clinical gastroenterology, 2006, Volume: 20, Issue:2

Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Deoxycytidine; Fluorouracil; Gemcitabine; Glutamates; Guanine; Humans; Irinotecan; Organoplatinum Compounds; Palliative Care; Pancreatic Neoplasms; Pemetrexed; Taxoids; Topoisomerase I Inhibitors

2006